TOI Oncology Institute Inc

Price (delayed)

$0.5277

Market cap

$39.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.81

Enterprise value

$123.06M

Highlights
TOI's revenue is up by 25% year-on-year and by 6% since the previous quarter
The EPS has plunged by 50% YoY but it has grown by 12% from the previous quarter
Oncology Institute's net income has decreased by 17% YoY but it has increased by 15% QoQ
TOI's equity has dropped by 58% year-on-year and by 28% since the previous quarter
The quick ratio has contracted by 25% from the previous quarter and by 19% YoY

Key stats

What are the main financial stats of TOI
Market
Shares outstanding
74.44M
Market cap
$39.28M
Enterprise value
$123.06M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.95
Price to sales (P/S)
0.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.36
Earnings
Revenue
$342.71M
EBIT
-$51.74M
EBITDA
-$45.64M
Free cash flow
-$40.08M
Per share
EPS
-$0.81
Free cash flow per share
-$0.54
Book value per share
$0.56
Revenue per share
$4.62
TBVPS
$2.43
Balance sheet
Total assets
$204.53M
Total liabilities
$163.24M
Debt
$119.84M
Equity
$41.3M
Working capital
$95.42M
Liquidity
Debt to equity
2.9
Current ratio
3.08
Quick ratio
2.73
Net debt/EBITDA
-1.84
Margins
EBITDA margin
-13.3%
Gross margin
16.8%
Net margin
-16.9%
Operating margin
-18.1%
Efficiency
Return on assets
-26.8%
Return on equity
-90.7%
Return on invested capital
-21.5%
Return on capital employed
-32.6%
Return on sales
-15.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TOI stock price

How has the Oncology Institute stock price performed over time
Intraday
1.48%
1 week
5.54%
1 month
19.93%
1 year
-41.7%
YTD
-74.13%
QTD
14.72%

Financial performance

How have Oncology Institute's revenue and profit performed over time
Revenue
$342.71M
Gross profit
$57.44M
Operating income
-$62.12M
Net income
-$57.77M
Gross margin
16.8%
Net margin
-16.9%
Oncology Institute's operating margin has increased by 49% YoY and by 24% from the previous quarter
The operating income rose by 36% year-on-year and by 19% since the previous quarter
TOI's revenue is up by 25% year-on-year and by 6% since the previous quarter
The company's net margin rose by 19% QoQ and by 6% YoY

Growth

What is Oncology Institute's growth rate over time

Valuation

What is Oncology Institute stock price valuation
P/E
N/A
P/B
0.95
P/S
0.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.36
The EPS has plunged by 50% YoY but it has grown by 12% from the previous quarter
TOI's equity has dropped by 58% year-on-year and by 28% since the previous quarter
The stock's P/B is 47% less than its last 4 quarters average of 1.8
The P/S is 63% less than the last 4 quarters average of 0.3
TOI's revenue is up by 25% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Oncology Institute business performance
The company's return on equity has shrunk by 118% YoY and by 4.3% QoQ
The ROA is down by 32% year-on-year but it is up by 12% since the previous quarter
The ROS has grown by 20% from the previous quarter and by 6% YoY
The company's return on invested capital rose by 10% QoQ but it fell by 5% YoY

Dividends

What is TOI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TOI.

Financial health

How did Oncology Institute financials performed over time
The total assets is 25% more than the total liabilities
The current ratio has contracted by 25% from the previous quarter and by 22% YoY
The quick ratio has contracted by 25% from the previous quarter and by 19% YoY
The company's debt is 190% higher than its equity
The debt to equity has soared by 159% YoY and by 38% from the previous quarter
TOI's equity has dropped by 58% year-on-year and by 28% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.